Apraxia Clinical Trials

Find Apraxia Clinical Trials Near You

A Single Case Experimental Design Study of Motor Speech Treatment for Children With Childhood Apraxia of Speech and Rare Genetic Conditions

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this trial is to learn if speech therapy can improve speech accuracy in children with rare genetic conditions and childhood apraxia of speech (CAS). This study will look at each child individually. Participants will complete 4-weeks of motor speech therapy (3 times per week) and will complete speech assessments before, during and after therapy to measure change. The motor speech therapy will be either Rapid Syllable Transition Treatment (ReST) or Dynamic Temporal and Tactile Cueing (DTTC). Assignment to ReST or DTTC will be based on the participant's age and speech ability. This trial will not compare ReST and DTTC.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 16
Healthy Volunteers: f
View:

• Children aged between 3 and 16 years, with a confirmed genetic condition and a diagnosis of childhood apraxia of speech; English as the primary language at home; able to participate in speech therapy 3 times per week for 4 weeks

Locations
Other Locations
Australia
Murdoch Children's Research Institute
RECRUITING
Melbourne
Contact Information
Primary
Miya D St John, PhD
miya.stjohn@mcri.edu.au
+610399366586
Backup
Maddy K Hill, MSpPath
maddy.hill@mcri.edu.au
+610399366586
Time Frame
Start Date: 2026-07-01
Estimated Completion Date: 2028-12
Participants
Target number of participants: 20
Treatments
Experimental: Motor speech therapy
DTTC or ReST
Related Therapeutic Areas
Sponsors
Leads: Murdoch Childrens Research Institute

This content was sourced from clinicaltrials.gov